Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
03/11/2004 | US20040049150 Vaccines |
03/11/2004 | US20040048934 Self-emulsifying drug delivery system |
03/11/2004 | US20040048932 Anesthetic e.g., sevoflurane, enflurane, isoflurane, methoxyflurane, or desflurane, containing a Lewis acid inhibitor |
03/11/2004 | US20040048931 Modafinil pharmaceutical compositions |
03/11/2004 | US20040048929 E.g., N-(4-fluorophenylsulfonyl)-L-valyl-L-leucinal stabilized with a lipid; improved absorption and penetration; treating ischemia, immune diseases, Alzheimer's disease, osteoporosis, brain disorders, eye diseases, osteoporosis |
03/11/2004 | US20040048924 Ibuprofen composition |
03/11/2004 | US20040048906 Synergistic combinations of amlodipine and atorvastatin used to treat angina pectoris, atherosclerosis, combined hypertension and hyperlipidemia and to treat subjects with symptoms of cardiac risk |
03/11/2004 | US20040048896 Treating gastric acid disorders by orally administering a proton pump inhibitor and a mixture of buffers |
03/11/2004 | US20040048829 Molecular inclusion compounds |
03/11/2004 | US20040048819 Complexes for transferring nucleic acids into cells |
03/11/2004 | US20040048786 Antibiotic coating for porous bodies and method for its production as well as its use |
03/11/2004 | US20040048784 With a varient of a protein synthesis inactivating toxin; a viral protease cleavage site is interposed between the A and B chains; variant of the type II ribosome inactivating protein is activated by digestion of the viral protease |
03/11/2004 | US20040048783 Acidic insulin preparations having improved stability |
03/11/2004 | US20040048782 Colloidal suspension of submicronic particles for carrying hydrophilic active principles (insulin) and method for preparing same |
03/11/2004 | US20040048777 Compounds and compositions for delivering active agents |
03/11/2004 | US20040048754 Capable of releasing perfumery, flavor, insect repellent or attractant, bactericide or fungicides |
03/11/2004 | US20040048289 A protein specific to a magnetic particle membrane, DNA which encodes the protein and their uses |
03/11/2004 | US20040047930 For topical application |
03/11/2004 | US20040047917 Drug delivery and targeting with vitamin B12 conjugates |
03/11/2004 | US20040047910 Suppository and composition comprising at least one polyethylene glycol |
03/11/2004 | US20040047903 For use in therapy of cancer |
03/11/2004 | US20040047900 Treatment of posterior capsule opacification |
03/11/2004 | US20040047882 Use of an oil-in-water emulsion as adjuvant for vaccines to be applied contralaterally, the emulsion comprising approx. 5% squalene, 0.5% polysorbate 80 and 0.5% sorbitan trioleate in aqueous citrate buffer pH 6.5 |
03/11/2004 | US20040047865 For preventing hyperacute rejection of xenografts or at least reducing the extent or rate of rejection |
03/11/2004 | US20040047850 Bifidobacteria and preparations containing them |
03/11/2004 | US20040047835 Combinations of drug conjugates with other therapeutic agents, including chemotherapy drugs. The invention also provides methods of using the combinations for the treatment of diseases associated with cell proliferation such as tumors |
03/11/2004 | US20040047824 Topical use containing at least one oxidation-sensitive hydrophilic active principle and at least one maleic anhydride copolymer, comprising one or more maleic anhydride comonomers and one or more comonomers selected from the group |
03/11/2004 | US20040047811 Aerodynamically light particles for pulmonary drug delivery |
03/11/2004 | US20040047809 An aerosol solution composition for use in an aerosol inhaler comprises an active material, a propellant containing a hydrofluoroalkane, a cosolvent and optionally a low volatility component to increase the mass median aerodynamic diameter of |
03/11/2004 | US20040047807 Neurotoxic substances, which have a toxic effect in particular for the axon and the nociceptive nerve endings, for the preparation of an agent for the treatment of joint pain. |
03/11/2004 | DE10334820A1 Pharmazeutische Zusammensetzungen mit antibiotischer Aktivität Pharmaceutical compositions having antibiotic activity |
03/11/2004 | DE10240894A1 Verstärkung der Resorption von Subtanzen über die Haut und Schleimhaut Enhance the absorption of Subtanzen through the skin and mucous membrane |
03/11/2004 | DE10240418A1 Formulierung zur Einschleusung von Nukleinsäuren in eukaryotische Zellen Formulation for the introduction of nucleic acids in eukaryotic cells |
03/11/2004 | DE10240035A1 Biogene Polyester-Partikel definierter Größe mit funktionalisierten Oberflächen:Herstellungsverfahren und pharmazeutische Zubereitungen, in denen diese enthalten sind Biogenic polyester particles of defined size with functionalized surfaces: Method and pharmaceutical preparations in which they are contained |
03/11/2004 | CA2502734A1 Medicinal composition for periodontal pocket administration containing bisphosphonic acid derivative or its salt as the active ingredient |
03/11/2004 | CA2497255A1 Method for producing biodegradable, functionalised polymer particles, and use of the same as medicament carriers |
03/11/2004 | CA2497121A1 Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders |
03/11/2004 | CA2497116A1 Buccal, polar and non-polar spray or capsule containing drugs for treating allergies or asthma |
03/11/2004 | CA2497086A1 Method of controlling pharmacokinetics of immunomodulatory compounds |
03/11/2004 | CA2497047A1 Adzymes and uses thereof |
03/11/2004 | CA2496550A1 Composition based on triethyl citrate for the treatment of bacterial infections of the skin |
03/11/2004 | CA2496470A1 Enzyme activated self-immolative n-substituted nitrogen mustard prodrugs |
03/11/2004 | CA2496314A1 Methods of treating idiopathic pulmonary fibrosis |
03/11/2004 | CA2495793A1 Breath freshening and oral cleansing product using cardamom oil |
03/11/2004 | CA2495210A1 Modified transferrin fusion proteins |
03/11/2004 | CA2495207A1 Modified transferin-antibody fusion proteins |
03/11/2004 | CA2495144A1 Methods and reagents for treating infections of clostridium difficile and diseases associated therewith |
03/11/2004 | CA2495064A1 Breath freshening and oral cleansing product using salicylaldehyde |
03/11/2004 | CA2495057A1 Breath freshening and oral cleansing product |
03/10/2004 | EP1396266A1 Aqueous cilostazol preparation for injection |
03/10/2004 | EP1396265A1 Ion exchange resins for alleviation of upper gastrointestinal irritation |
03/10/2004 | EP1396263A1 Film coating for tablets and caplets |
03/10/2004 | EP1395604A1 Novel anti inflammatory 17.alpha.-heterocyclic-esters of 17.beta.-carbothioate androstane derivatives |
03/10/2004 | EP1395294A2 Pulmonary administration of chemically modified insulin |
03/10/2004 | EP1395290A2 Cytotoxic cd44 antibody immunoconjugates |
03/10/2004 | EP1395279A2 Use of neublastin polypeptides for treating neuropathic pain |
03/10/2004 | EP1395278A2 Ocular tear growth factor-like protein |
03/10/2004 | EP1395273A1 Targeted delivery of drugs for the treatment of viral infections |
03/10/2004 | EP1395264A2 Targeted delivery of drugs for the treatment of parasitic infections |
03/10/2004 | EP1395258A1 Oral controlled release pharmaceutical composition for one-a-day therapy for the treatment and prophylaxis of cardiac and circulatory diseases |
03/10/2004 | EP1395254A1 Oral pharmaceutical composition containing a statin derivative |
03/10/2004 | EP1395249A1 Soft elastic capsules comprising ritonavir and/or lopinavir |
03/10/2004 | EP1395247A2 Oxcarbazepine dosage forms |
03/10/2004 | EP1395244A1 Oxidized collagen formulations for use with non-compatible pharmaceutical agents |
03/10/2004 | EP1395242A1 Liquid pharmaceutical composition |
03/10/2004 | EP1395240A1 Modification of the sustained release profile |
03/10/2004 | EP1395231A1 Preparation for the removal of abnormal keratin material |
03/10/2004 | EP1395224A2 Tamper resistant oral dosage form |
03/10/2004 | EP1395215A1 Quinolone carboxylic acid compositions and related methods of treatment |
03/10/2004 | EP1303249B1 Antimycotic nail varnish composition |
03/10/2004 | EP1242314B1 Production of pyrogen controlled water |
03/10/2004 | EP1234043B1 Constructs for delivery of therapeutic agents to neuronal cells |
03/10/2004 | EP1231911B1 Directly compressible, ultra fine acetaminophen compositions and process for producing same |
03/10/2004 | EP1180062B1 Method for producing morphologically uniform micro and nanoparticles using micromixers |
03/10/2004 | EP1100499B1 Use of eletriptan for the prevention of migraine recurrence |
03/10/2004 | EP1030660B1 A transdermal drug delivery system for anti-inflammatory analgesic agent comprising diclofenac diethylammonium salt, and the manufacturing method thereof |
03/10/2004 | EP0980245B1 Use of misoprostol or/and misoprostol acid for the treatment of erectile dysfunction |
03/10/2004 | EP0938342B1 Injectable combination of polymers for the manufacture of an in situ implant |
03/10/2004 | EP0918547B1 Radiolabeled annexins |
03/10/2004 | EP0868198B1 FCepsilon-PE CHIMERIC PROTEIN FOR TARGETED TREATMENT OF ALLERGY RESPONSES, A METHOD FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
03/10/2004 | EP0854718B1 Novel composition containing an acid-labile benzimidazole and process for its preparation |
03/10/2004 | EP0820300B1 Controlled release biodegradable nanoparticles containing insulin |
03/10/2004 | EP0792147B1 Pharmaceutical composition comprising non-steroidal anti-inflammatory drugs |
03/10/2004 | EP0769955B1 Non-antigenic amine derived polymers and polymer conjugates |
03/10/2004 | EP0767634B1 Microcapsules for administration of neuroactive agents |
03/10/2004 | CN1481264A Medicament-loaded transdermal reservoir and method for its formation |
03/10/2004 | CN1481257A Compsn and its method |
03/10/2004 | CN1481253A Drugs and foods improving quality of life and process for producng same |
03/10/2004 | CN1481252A Stabilized Inteferon compsns |
03/10/2004 | CN1481247A Use of zolendronate for mfg. medicament for treatment of bone metabolism diseases |
03/10/2004 | CN1481241A Therapeutic combination of amlodipine and benazepril/benazeprilat |
03/10/2004 | CN1481237A Method for producing organic solvent-free lycopene concentrate, resulting concentrate and compsn comprising said concentrate |
03/10/2004 | CN1481235A Microgranules based on active principle and method for making same |
03/10/2004 | CN1480528A Bifidobacterium and products contg same |
03/10/2004 | CN1480496A Polyacrylic acid film forming compsn. |
03/10/2004 | CN1480226A Antibiotic coating of porous body, its prepn. and application |
03/10/2004 | CN1480219A Biodegradable multiple targeting hydrogel orientated to eolon as well as its preparation and application |
03/10/2004 | CN1480218A Medicinal preparation of slowly-released bioactive substance, its prepn. and application |
03/10/2004 | CN1480193A Kuhseng targeting preparation and its preparing method |
03/10/2004 | CN1480140A Injection medication combination of nimodipine and its preparing method |